Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsStøve, Heidi Kristine
Sandahl, Julie Damgaard
Asdahl, Peter H
Jónsson, Ólafur G
MetadataShow full item record
CitationExtramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). 2017, 64 (12) Pediatr Blood Cancer
ÚtdrátturThe prognostic significance of extramedullary leukemia (EML) in childhood acute myeloid leukemia is not clarified.
This population-based study included 315 children from the NOPHO-AML 2004 trial.
At diagnosis, 73 (23%) patients had EML: 39 (12%) had myeloid sarcoma, 22 (7%) had central nervous system disease, and 12 (4%) had both. EML was associated with young age (median age: 2.6 years), a high white blood cell count (median: 40 × 10(9) /l), M5 morphology (40%), and 11q23/MLL (KMT2A) rearrangements (34%). No patient received involved field radiotherapy. Five-year event-free survival did not differ significantly between the EML and the non-EML patients (54% vs. 45%, P = 0.57), whereas 5-year overall survival (OS) was significantly lower in the EML group (64% vs. 73%, P = 0.04). The risk of induction death was significantly higher for EML patients (8% vs. 1%, P = 0.002). There was a trend toward a lower risk of relapse for EML patients (5-year cumulative incidence of relapse 33% vs. 49%, P = 0.16). Traumatic lumbar puncture did not adversely affect survival in this cohort.
EML was associated with increased risk of induction death impacting the OS. No patients relapsed at the primary site of the myeloid sarcoma despite management without radiotherapy.
Lu00FDsingTo access publisher's full text version of this article click on the hyperlink below
RightsArchived with thanks to Pediatric blood & cancer
- Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group.
- Authors: Dusenbery KE, Howells WB, Arthur DC, Alonzo T, Lee JW, Kobrinsky N, Barnard DR, Wells RJ, Buckley JD, Lange BJ, Woods WG
- Issue date: 2003 Oct
- Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
- Authors: Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG
- Issue date: 2012 Apr
- Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review.
- Authors: Byrd JC, Edenfield WJ, Shields DJ, Dawson NA
- Issue date: 1995 Jul
- Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.
- Authors: Espersen ADL, Noren-Nyström U, Abrahamsson J, Ha SY, Pronk CJ, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Zeller B, Palmqvist L, Hasle H
- Issue date: 2018 Jul
- Is acute myeloid leukemia a liquid tumor?
- Authors: Ohanian M, Faderl S, Ravandi F, Pemmaraju N, Garcia-Manero G, Cortes J, Estrov Z
- Issue date: 2013 Aug 1